SUNPHARMA - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth

1.3%

0.4%

2.5%

1.7%

3.2%

12.5%

31.5%

10y

6.5%

all

17.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,707 1.3%

1,555

1,851

Company Overview

Sales

51,602 Cr

Growth: 8.8%

Profit after Tax

11,434 Cr

Growth: 3.4%

Large Cap

4,09,650 Cr

P/E: 35.8x

Industry P/E: 32.1x

Fundamentals

Sales (Cr)	₹ 51,602
Growth	8.8%
EBITDA	28.0%
P/S	7.9x
Dividend	0.9%
P/E	35.8x
Book Value	₹ 302
PEG Ratio	4.1x
ROE	16.8%
P/B	5.7x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

7.37 %

Icici Prudential Value Discovery Fund And Various Fund Accounts

3.68 %

Sbi-Etf Nifty 50 And Various Fund Accounts

1.94 %

Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts

1.37 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts

1.24 %

Promoters

Shanghvi Finance Private Limited

40.3 %

Dilip.S.Shanghvi

9.6 %

Aditya Medisales Limited

1.67 %

Raksha S.Valia

1.2 %

Sudhir V.Valia

0.6 %

Others

Llp

2.89 %

Lakshdeep Investments & Finance (P) Ltd.

1.18 %

Iepf

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.

Belongs to (52 Indices) view more

Investors (335)

subson

merrill....

the.mtbj...

Followers (136)

bharath....

kiran198...

anil